Projected Income Statement: Ingevity Corporation

Forecast Balance Sheet: Ingevity Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 975 1,396 1,371 1,333 1,130 1,040 937 883
Change - 43.18% -1.79% -2.77% -15.23% -8% -9.9% -5.76%
Announcement Date 23/02/22 27/02/23 21/02/24 18/02/25 25/02/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Ingevity Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 103.8 142.5 109.8 77.6 57.7 49 51.5 52
Change - 37.28% -22.95% -29.33% -25.64% -15.08% 5.1% 0.97%
Free Cash Flow (FCF) 1 189.2 170.6 95.3 51 273.5 275 244 258.5
Change - -9.83% -44.14% -46.48% 436.27% 0.55% -11.27% 5.94%
Announcement Date 23/02/22 27/02/23 21/02/24 18/02/25 25/02/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Ingevity Corporation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

         
EBITDA Margin (%) - 30.34% 27.13% 23.45% 25.79% 30.83% 34.45% 36.77% 36.95%
EBIT Margin (%) - 22.44% 20.61% 4.54% 18.09% 22.58% 25.92% 27.95% 28.58%
EBT Margin (%) - 11.7% 16.16% -0.6% -38.08% -11.02% 13.62% 22.11% 23.39%
Net margin (%) - 8.49% 12.68% -0.32% -30.6% -12.96% 12.2% 17.02% 18.28%
FCF margin (%) - 13.6% 10.23% 5.63% 3.63% 21.21% 24.8% 21.58% 22.39%
FCF / Net Income (%) - 160.2% 80.62% -1,764.81% -11.85% -163.67% 203.18% 126.82% 122.51%

Profitability

         
ROA 8.18% 8% 8.2% 6.45% 7.16% 8.91% - - -
ROE 30.93% 17.95% 30.84% -0.81% -104.11% -133.66% - - -

Financial Health

         
Leverage (Debt/EBITDA) - 2.31x 3.08x 3.46x 3.68x 2.84x 2.72x 2.25x 2.07x
Debt / Free cash flow - 5.15x 8.18x 14.39x 26.14x 4.13x 3.78x 3.84x 3.42x

Capital Intensity

         
CAPEX / Current Assets (%) - 7.46% 8.54% 6.49% 5.52% 4.48% 4.42% 4.55% 4.5%
CAPEX / EBITDA (%) - 24.59% 31.48% 27.67% 21.4% 14.52% 12.83% 12.39% 12.19%
CAPEX / FCF (%) - 54.86% 83.53% 115.22% 152.16% 21.1% 17.82% 21.11% 20.12%

Items per share

         
Cash flow per share 1 - 7.307 - - - 9.149 8.65 7.75 9.3
Change - - - - - - -5.46% -10.4% 20%
Dividend per Share 1 - - - - - - - - -
Change - - - - - - - - -
Book Value Per Share 1 - 17.16 18.72 - 5.377 0.837 - - -
Change - - 9.11% - - -84.43% - - -
EPS 1 - 2.95 5.5 -0.15 -11.85 -4.61 3.875 5.76 6.4
Change - - 86.44% -102.73% -7,800% 61.1% 184.06% 48.65% 11.11%
Nbr of stocks (in thousands) - 39,286 37,372 36,231 36,349 35,964 34,772 34,772 34,772
Announcement Date - 23/02/22 27/02/23 21/02/24 18/02/25 25/02/26 - - -
1USD
Estimates
2026 *2027 *
P/E 19.3x 13x
PBR - -
EV / Sales 3.28x 3.13x
Yield - -

EPS & Dividend

Y-o-Y evolution of P/E

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
74.80USD
Average target price
89.00USD
Spread / Average Target
+18.98%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NGVT Stock
  4. Financials Ingevity Corporation